Kondo M - Search Results

1

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, Aoe K, Tsuji T, Takiguchi Y, Takayama K, Komura N, Takiguchi T, Eguchi K. Katakami N, et al. Among authors: kondo m. Cancer. 2018 Feb 1;124(3):606-616. doi: 10.1002/cncr.31128. Epub 2017 Dec 4. Cancer. 2018. PMID: 29205286 Free PMC article. Clinical Trial.

2

Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer.

Uchiyama M, Usami N, Kondo M, Mori S, Ito M, Ito G, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Minna JD, Shimokata K, Sekido Y. Uchiyama M, et al. Among authors: kondo m. Int J Cancer. 2003 Dec 20;107(6):962-9. doi: 10.1002/ijc.11493. Int J Cancer. 2003. PMID: 14601056 Free article.

3

Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.

Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN, Kondo M, Minna JD, Roth JA, Ji L. Uno F, et al. Among authors: kondo m. Cancer Res. 2004 May 1;64(9):2969-76. doi: 10.1158/0008-5472.can-03-3702. Cancer Res. 2004. PMID: 15126327

4

Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K, Sekido Y. Ito G, et al. Among authors: kondo m. Cancer Res. 2004 Jun 1;64(11):3838-43. doi: 10.1158/0008-5472.CAN-04-0185. Cancer Res. 2004. PMID: 15172991

5

Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.

Shimizu M, Kondo M, Ito Y, Kume H, Suzuki R, Yamaki K. Shimizu M, et al. Among authors: kondo m. Cancer Detect Prev. 2005;29(2):175-80. doi: 10.1016/j.cdp.2004.09.001. Epub 2004 Nov 14. Cancer Detect Prev. 2005. PMID: 15829378

6

Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.

Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K, Sekido Y. Ito M, et al. Among authors: kondo m. Cancer Lett. 2005 Jul 8;225(1):131-9. doi: 10.1016/j.canlet.2004.10.041. Epub 2004 Dec 22. Cancer Lett. 2005. PMID: 15922865

7

Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.

Kondo M, Yokoyama T, Fukui T, Yoshioka H, Yokoi K, Nagasaka T, Imaizumi K, Kume H, Hasegawa Y, Shimokata K, Sekido Y. Kondo M, et al. Lung Cancer. 2005 Dec;50(3):385-91. doi: 10.1016/j.lungcan.2005.06.008. Epub 2005 Sep 2. Lung Cancer. 2005. PMID: 16140420

8

EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification.

Yokoyama T, Kondo M, Goto Y, Fukui T, Yoshioka H, Yokoi K, Osada H, Imaizumi K, Hasegawa Y, Shimokata K, Sekido Y. Yokoyama T, et al. Among authors: kondo m. Cancer Sci. 2006 Aug;97(8):753-9. doi: 10.1111/j.1349-7006.2006.00233.x. Cancer Sci. 2006. PMID: 16863509 Free article.

9

RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.

Sato N, Fukui T, Taniguchi T, Yokoyama T, Kondo M, Nagasaka T, Goto Y, Gao W, Ueda Y, Yokoi K, Minna JD, Osada H, Kondo Y, Sekido Y. Sato N, et al. Among authors: kondo m, kondo y. Int J Cancer. 2007 Feb 1;120(3):543-51. doi: 10.1002/ijc.22328. Int J Cancer. 2007. PMID: 17096327 Free article.

10

Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study.

Ichikawa M, Suzuki R, Kataoka K, Noda Y, Shindoh J, Matsumoto S, Tanikawa Y, Suzuki K, Baba K, Shindo Y, Kondo M, Imaizumi K, Kume H, Hasegawa Y, Takagi K, Taniguchi H. Ichikawa M, et al. Among authors: kondo m. Lung Cancer. 2010 Sep;69(3):319-22. doi: 10.1016/j.lungcan.2009.11.021. Epub 2010 Jan 6. Lung Cancer. 2010. PMID: 20053476 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,366 results

Search Page